Health
U.S. baby formula supply is still vulnerable, former FDA official tells lawmakers
Frank Yiannas, former deputy commissioner of the office of food policy and response at the Food and Drug Administration (FDA), speaks during a House Oversight and Accountability Subcommittee hearing in Washington, DC, on Tuesday, March 28, 2023. Ting Shen | Bloomberg | Getty Images The U.S. supply of infant formula industry is still vulnerable to […]
Read More
With travel nurses making $150 an hour, hospital systems are forced to innovate
Cassie Jupin grew up wanting to be a nurse. She set her sights on a job at St. Peter’s Health Partners hospital in Albany, New York, and landed a position in the same maternity ward where she was born. “Knowing that I can come back to work every single day and work with a group […]
Read More
Walgreens revenue rises despite sharp decline in demand for Covid tests, vaccines
A man walks near a Walgreens pharmacy on March 09, 2023 in New York City. Leonardo Munoz | Corbis News | Getty Images Walgreens Boots Alliance on Tuesday said its quarterly profit declined more than 20%, driven by sharply lower Covid vaccine volumes and test sales compared to last winter, when the Covid Omicron variant […]
Read More
Labcorp to pay $2.1 million to settle DOJ lawsuit for allegedly overbilling Defense Department
Laboratory Corporation of America will pay the U.S. $2.1 million to settle allegations that it overbilled the Department of Defense for genetic tests that involved children and fetuses, the Justice Department announced Monday. A former LabCorp employee turned whistleblower, Donna Hecker-Gross, sued the diagnostic testing company in 2018 on behalf of the federal government under […]
Read More
BioNTech shares slip on gloomy Covid vaccine sales outlook
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garrido | Reuters Shares of BioNTech on Monday slid by more than 6% in morning trading after the German drugmaker shared a gloomy 2023 sales outlook for its […]
Read More
Wyoming abortion ban blocked due to Obamacare-era amendment
Abortion is legal in Wyoming again, oddly enough as the result of a state constitutional amendment pushed by conservatives opposed to Obamacare more than a decade ago. Teton County District Court Judge Melissa Owens in a ruling Wednesday temporarily blocked enforcement of the state’s newly enacted abortion ban that took effect Sunday. Owens’ decision pointed […]
Read More
Carl Icahn claims Illumina directors got extra insurance to close ‘disastrous’ $7.1 billion Grail deal
Carl Icahn on Friday alleged that Illumina‘s directors demanded extra personal liability insurance before the biotech company signed off on a $7.1 billion acquisition of cancer test developer Grail in 2021. The claim is the latest development in a brewing proxy fight between the activist investor and San Diego-based Illumina, who have been trading jabs […]
Read More
Pfizer’s Covid drug Paxlovid may reduce the risk of developing long Covid, study says
A prescription for Pfizers Paxlovid tablets outside of his apartment in Philadelphia, Pennsylvania on April 25, 2022. (Photo by Rachel Wisniewski/For the Washington Post) Rachel Wisniewski | The Washington Post | Getty Images People who take Pfizer‘s Covid antiviral treatment Paxlovid shortly after infection may reduce their risk of developing long Covid, regardless of their […]
Read More
Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD
A logo on the Sanofi exhibition space at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris, France June 15, 2022. Benoit Tessier | Reuters Shares of Sanofi and Regeneron both jumped by more than 6% on Thursday after the pharmaceutical companies released promising data showing their […]
Read More
FDA advisors vote against effectiveness of Biogen’s ALS drug for rare and aggressive form of the disease
A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration’s independent panel of advisors on Wednesday voted against the effectiveness of Biogen’s investigational ALS drug for a rare and aggressive form of the disease. The drug tofersen […]
Read More